Key result
Intravenous aminophylline therapy showed no overall difference in spirometric values compared to control regimens for the treatment of severe, acute asthma.
Why the study?
Does intravenous aminophylline improve spirometric values in patients with severe, acute asthma compared to other bronchodilators?
Meta-Analysis
Does intravenous aminophylline improve spirometric values in patients with severe, acute asthma compared to other bronchodilators?
Despite widespread practice, available trials do not provide adequate evidence to support or reject the use of aminophylline in the treatment of severe, acute asthma.
Answers are grounded in this paper and cite their sources.
Does not support routine IV aminophylline in severe acute asthma; challenges longstanding practice and warrants guideline reevaluation.
Aminophylline is routinely recommended as a basic part of the emergency treatment of asthma. A comprehensive search found 13 reports of controlled trials of intravenous aminophylline therapy in severe, acute asthma. These studies compared aminophylline therapy with treatment with either albuterol (salbutamol), epinephrine, or other bronchodilators. The 13 reports did not agree. Seven reported no difference in spirometric values between aminophylline treatment and the control regimens. Three found aminophylline treatment superior. Three favored the control regimen. The results of the 13 trials were reanalyzed and pooled. Overall, there was no difference between the aminophylline-treated groups and the control groups. Sensitivity analysis suggests that aminophylline therapy is ineffective alone but may be more effective than single-drug therapy when combined with an injected β-agonist. Despite widespread practice, available trials do not provide adequate evidence to support or reject the use of aminophylline in the treatment of severe, acute asthma. (JAMA1988;259:1678-1684)
No takes yet. Share an insight, caveat, or question.
Benjamin Littenberg (1988) conducted a meta-analysis in severe, acute asthma. Intravenous aminophylline vs. albuterol (salbutamol), epinephrine, or other bronchodilators was evaluated on spirometric values. Intravenous aminophylline therapy showed no overall difference in spirometric values compared to control regimens for the treatment of severe, acute asthma.
Synapse has enriched 10 related papers. Consider them for comparative context: